Journal of Clinical Epigenetics Open Access

  • ISSN: 2472-1158
  • Journal h-index: 10
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Methylation level of plasminogen activator inhibitor- 1 (PAI-1) in endometriosis

2nd International Congress on Epigenetics & Chromatin
November 06-08, 2017 | Frankfurt, Germany

Ririn Rahmala Febri, Andon Hestiantoro and Asmarinah

Indonesian Medical Education and Research Institute (IMERI), Indonesia
University of Indonesia, Indonesia

Scientific Tracks Abstracts: J Clin Epigenet

Abstract:

Introduction: Endometriosis that affects 10% women in the reproductive group is characterized by the presence of endometrium-like tissue outside of the uterine cavity, primarily in the ovaries. Endometriosis-associated pain can be caused by peritoneal inflammation, specific innervation, adhesion formation and cell invasion; whereas plasminogen activator system plays a role in this invasion. It has been known that plasminogen activator inhibitor-1 (PAI-1) level is higher in endometriotic cells than normal endometrial cells. In this study, we determined the methylation level of plasminogen activator inhibitor-1 (PAI-1) in association with endometriosis. Methods: We collected 16 ovarian endometriosis samples obtained from patients, as compared to 12 normal endometrium tissues obtained from healthy women. Each participant gave informed consent. We used methylation specific PCR (MSP) and ImageJ software to analyze the methylation level of PAI-1 gene. Results: We found that the methylation level of PAI-1 in endometriotic cells was lower 37.95%, than normal endometrial cells. In addition, there was a significantly different methylation level of PAI-1 gene between endometriosis (24.02�±7.22) and normal endometrium (61.97%�±9.62) (p<0.05). Conclusion: This study showed there was a hypomethylation in the promoter region of PAI-1 gene and might contribute in the high level of PAI-1 in endometriosis tissue.

Biography :

Ririn Rahmala Febri received her Master degree from Biomedical Sciences, Faculty of Medicine, Universitas Indonesia (FMUI). In 2016, she joined the Human Reproductive, Infertility, and Family Planning Cluster, Indonesian Medical Education and Research Institute (IMERI) FMUI. She has been involved in various science projects and researches. Her current research interest includes epigenetics, cell adhesion and gene expressions, especially in the reproductive fields.